Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Ivy Rx vs TrimRx

Ivy Rx costs $4 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Ivy Rx logo

Ivy Rx

7.3
★★★★☆3.7/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Ivy Rx →
VS
TrimRx logo

TrimRx

7.2
★★★★☆3.6/5

Best for: compounded semaglutide at $179/month

Visit TrimRx →

If you are choosing between Ivy Rx and TrimRx, the first difference is cost: Ivy Rx is $4 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Ivy Rx leads our six-part score, 7.3 to 7.2.

Ivy Rx vs TrimRx price

Ivy Rx is the cheaper way in: $175 a month against $179 a month at TrimRx. That is $4 less each month (2% lower), or about $48 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Ivy Rx ($175 a month vs $179 a month); tirzepatide is cheaper at TrimRx ($259 a month vs $275 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Ivy Rx prices compounded injections, while TrimRx prices compounded injections and brand-name pens.

If you want the FDA-approved brand rather than a compounded version, TrimRx is the only one of the two with a brand-name price.

Where each one treats patients

Ivy Rx lists 50 states, and TrimRx does not publish where it ships.

Pricing

Ivy Rx

StartingCompounded
$175/mo
semaglutide

Range up to $197/mo

StartingCompounded
$275/mo
tirzepatide

Range up to $297/mo

TrimRx

Starting (flat across doses)Compounded
$179$135/mo
Save 25% right now
semaglutide

GLP-1 starts at $179. The homepage shows a $299.00 list price struck through to $179.00 for the first month, and an email sign-up offer promises '$120 OFF' your first order, for a first month as low as $135. Multi-month bundles (formerly $209/$191/$174) are no longer published; plan prices appear only after the intake questionnaire.

Starting (flat across doses)Compounded
$259/mo
tirzepatide

The GLP-1 + GIP plan, which contains tirzepatide, starts at $259, down from an earlier $279 limited offer. Multi-month bundles (formerly $316/$299/$283) are no longer published; plan prices appear only after the intake questionnaire.

StartingBrand-name
$1249/mo
tirzepatide (mounjaro)

'Mounjaro® Starting at $1249' homepage tile; same branded-fulfillment caveat.

StartingBrand-name
$1249/mo
tirzepatide (zepbound)

'Zepbound® Starting at $1249' homepage tile; same branded-fulfillment caveat.

StartingBrand-name
$1579/mo
semaglutide (wegovy)

'Wegovy® Starting at $1579' homepage tile; same branded-fulfillment caveat.

What each price covers

Both prices cover the clinician visit, the medication itself and shipping.

Ivy Rx is silent on lab work and coaching.

TrimRx is silent on lab work and coaching.

Ivy Rx

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

TrimRx

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Ivy Rx scores 7.3 and TrimRx 7.2 out of 10.

Ivy Rx is stronger on trust & safety (7.5 vs 6.5) and accessibility (10.0 vs 5.0).

TrimRx is stronger on value (5.2 vs 3.0).

Effectiveness, user experience and support are within half a point.

How we score

Ivy Rx

7.3/10

Overall

TrimRx

7.2/10

Value25%

3.0A
vs
B
5.2

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

FDA warning letters

Neither Ivy Rx nor TrimRx has an FDA warning letter on record with us.

Features & Coverage

FeatureIvy RxTrimRx
Starting Price✓$175/mo$179/mo
Features3 features✓8 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Ivy Rx

Ivy Rx is a telehealth seller running tiered compounded semaglutide and tirzepatide programs.

Read our full Ivy Rx review →

About TrimRx

Three things TrimRx does not publish: the pharmacy that compounds its drugs, the states it serves, and any LegitScript certification. Specifics sit behind an intake quiz. What is visible is a cash-pay program with tiered monthly pricing plus multi-month bundles, no insurance, selling compounded semaglutide and tirzepatide shipped monthly at no shipping cost. Licensed US providers prescribe after reviewing an online medical history. The pitch is dose continuity and stable pricing: "switch and keep your current dose, no price hikes". Compounded GLP-1s are not FDA-approved.

Read our full TrimRx review →

Pros & Cons

Ivy Rx

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Ivy Rx

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

TrimRx

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $259 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to TrimRx

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Ivy Rx

Ivy Rx wins this one, 7.3 to 7.2, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $4 less each month than TrimRx. TrimRx fits better if compounded semaglutide at $179/month is your priority.

Choose Ivy Rx if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $175 a month.

Choose TrimRx if…

You want compounded semaglutide at $179/month and an opening price near $179 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

Ivy Rx vs TrimRx: FAQ

Ivy Rx. It starts at $175 a month; TrimRx starts at $179 a month, $4 more per month.
Yes, both sell semaglutide and tirzepatide.
Ivy Rx lists 50 states; TrimRx does not publish where it ships. Confirm your state before paying.
Both include the clinician visit, the medication itself and shipping.
Ivy Rx has none. TrimRx has none.
No. Neither Ivy Rx nor TrimRx pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.